Richard H Stanford Selected Research

Richard H Stanford Research Topics

Disease

38	Asthma (Bronchial Asthma) 05/2024 - 02/2002
32	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 01/2004
2	COVID-19 05/2024 - 11/2023
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 05/2019
2	Allergic Rhinitis 07/2011 - 07/2011
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Hypertension (High Blood Pressure) 02/2021
1	Cystic Fibrosis (Mucoviscidosis) 05/2019
1	Perennial Allergic Rhinitis 07/2011
1	Chronic Bronchitis 01/2009
1	Neoplasms (Cancer) 12/2008
1	Venous Thromboembolism 10/2008
1	Thrombocytopenia (Thrombopenia) 10/2008
1	Hemorrhage 11/2007
1	Rhinitis 11/2006
1	Lung Diseases (Lung Disease) 03/2005

Drug/Important Bio-Agent (IBA)

38	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 02/2002
17	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 02/2002
16	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2021 - 06/2007
16	Salmeterol Xinafoate (Serevent)FDA Link 01/2020 - 02/2004
10	Muscarinic AntagonistsIBA 12/2019 - 01/2017
8	vilanterolIBA 01/2021 - 01/2017
7	montelukast (Singulair)FDA Link 01/2013 - 02/2002
5	Bronchodilator Agents (Bronchodilators)IBA 02/2021 - 05/2010
5	fluticasone furoate FDA Link 01/2021 - 01/2019
5	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2014 - 07/2004
5	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2009 - 03/2005
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2020 - 07/2008
4	GSK573719IBA 01/2020 - 01/2017
3	LeukotrienesIBA 05/2003 - 02/2002
2	dupilumabIBA 05/2024 - 11/2023
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2021 - 01/2019
2	Formoterol Fumarate (Oxis)FDA Link 01/2021 - 01/2019
2	GoldIBA 12/2019 - 07/2019
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2012 - 07/2002
2	Nasal SpraysIBA 07/2011 - 07/2011
2	Enoxaparin (Lovenox)FDA LinkGeneric 10/2008 - 11/2007
2	Dalteparin (Dalteparin Sodium)FDA Link 10/2008 - 11/2007
1	mepolizumabIBA 05/2024
1	benralizumabIBA 05/2024
1	Antiviral Agents (Antivirals)IBA 05/2024
1	nirmatrelvir and ritonavir drug combinationIBA 05/2024
1	insulin receptor-related receptor (IRR)IBA 11/2023
1	Surface-Active Agents (Surfactants)IBA 01/2023
1	CholesterolIBA 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	SmokeIBA 12/2019
1	Oxygen (Dioxygen)IBA 01/2018
1	Prescription DrugsIBA 01/2018
1	A 7 (A-7)IBA 01/2018
1	Tiotropium Bromide (Spiriva)FDA Link 01/2017
1	SteroidsIBA 10/2016
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2013
1	PowdersIBA 04/2013
1	antineoplaston A10 (A 10)IBA 12/2008
1	AnticoagulantsIBA 10/2008
1	Fondaparinux (Arixtra)FDA Link 11/2007
1	Heparin (Liquaemin)FDA LinkGeneric 11/2007
1	Histamine Antagonists (Antihistamines)IBA 11/2006
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 05/2004
1	A 17 (A-17)IBA 05/2003
1	zafirlukast (Accolate)FDA LinkGeneric 02/2002

Therapy/Procedure

35	Therapeutics 11/2023 - 02/2002
19	Nebulizers and Vaporizers (Inhaler) 10/2021 - 02/2004
4	Dry Powder Inhalers 10/2021 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 06/2007
1	Continuity of Patient Care 01/2021
1	Metered Dose Inhalers (Metered Dose Inhaler) 01/2020
1	Ambulatory Care (Outpatient Care) 01/2019
1	Patient Readmission 01/2018